Traci Nixon
Family · Salisbury, NCNPI 1083936710
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 442 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 21.1% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,361, 2.2 times the $1,063 reported in 2021. Among family clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 442 payments — averaging $17.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$2K
- AbbVie$1K
- AstraZeneca$781
- Lilly USA, LLC$772
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$503
- Axsome Therapeutics, Inc.$426
- plus $3K from 27 others
What the payments were for
- Food & beverage$7,829100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 94 | $1,654 |
| AbbVie | 84 | $1,173 |
| AstraZeneca | 35 | $781 |
| Lilly USA, LLC | 46 | $772 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 24 | $503 |
| Axsome Therapeutics, Inc. | 22 | $426 |
| Exact Sciences | 13 | $332 |
| GSK | 16 | $257 |
| Bayer | 15 | $248 |
| Amgen | 13 | $216 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $198 |
| Tris Pharma Inc | 9 | $144 |
| Boehringer Ingelheim | 6 | $136 |
| Idorsia Pharmaceuticals US Inc | 5 | $91 |
| Pfizer | 4 | $90 |
| Sanofi-aventis U.S. LLC | 4 | $89 |
| Almatica Pharma LLC | 6 | $89 |
| Collegium Pharmaceutical, Inc. | 5 | $82 |
| Vanda Pharmaceuticals Inc. | 3 | $68 |
| Amarin Pharma, Inc. | 3 | $55 |
| Ironshore Pharmaceuticals Inc. | 3 | $49 |
| Irhythm Technologies, Inc. | 3 | $49 |
| Otsuka America Pharmaceutical, Inc. | 2 | $49 |
| Astellas Pharma US Inc | 2 | $43 |
| Corcept Therapeutics | 2 | $36 |
| Seqirus USA Inc | 2 | $35 |
| Cranial Technologies, Inc | 2 | $34 |
| Medline Industries LP | 1 | $26 |
| Dexcom, Inc. | 1 | $24 |
| Eisai Inc. | 1 | $22 |
| Lundbeck LLC | 1 | $21 |
| Daiichi Sankyo Inc. | 1 | $20 |
| Abbott | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BREZTRI$125
- Cologuard Collection Kit$112
- Ozempic$102
- Wegovy$101
How this compares
$7,829 in reported general payments places this provider in the 95th percentile of 4,522 family providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 63 | $71,354 |
| OzempicSemaglutide | 71 | $71,233 |
| JardianceEmpagliflozin | 39 | $43,516 |
| FarxigaDapagliflozin Propanediol | 51 | $38,820 |
| EliquisApixaban | 37 | $29,790 |
| Dupixent PenDupilumab | 12 | $28,676 |
| TrulicityDulaglutide | 26 | $28,616 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 35 | $22,258 |
| Tresiba Flextouch U-100Insulin Degludec | 17 | $16,780 |
| RybelsusSemaglutide | 11 | $10,715 |
| Xtampza ErOxycodone Myristate | 12 | $8,594 |
| XareltoRivaroxaban | 12 | $7,850 |
| TrintellixVortioxetine Hydrobromide | 16 | $7,170 |
| Bevespi AerosphereGlycopyrrolate/Formoterol Fum | 14 | $5,829 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 80 | $2,233 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $772 | $99,97089 claims |
| Novo NordiskOzempic, Rybelsus | $1,654 | $81,94882 claims |
| AstraZenecaFarxiga, Bevespi Aerosphere | $781 | $44,64965 claims |
| Boehringer IngelheimJardiance | $136 | $43,51639 claims |
| PfizerEliquis | $90 | $29,79037 claims |
| GSKTrelegy Ellipta | $257 | $22,25835 claims |
| Collegium Pharmaceutical, Inc.Xtampza Er | $82 | $8,59412 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $198 | $7,17016 claims |
| Almatica Pharma LLCSertraline Hcl | $89 | $70070 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,522 family providers in North Carolina.
Other family in Salisbury
- Karen GarmonSalisbury$15K
- Leslie ByrneFayetteville$482K
- Michele CerraRaleigh$332K
- Anne LakeArchdale$306K
- Carrie PettitRaleigh$298K
- Nicole RothmanDurham$268K
- Meredith LeaYanceyville$253K
- Jennifer GibbsRaleigh$216K
- Juanita PerkinsDurham$213K
- Teresa DossWilmington$137K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.